Live Breaking News & Updates on Miami itch center

Stay informed with the latest breaking news from Miami itch center on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Miami itch center and stay connected to the pulse of your community

Neuropeptide in Blood to Help Diagnose Chronic Itch

B-type natriuretic peptide (BNP) plays a key role in chronic itch severity and can help to identify certain types of itch with a simple blood test, according t

Miami , Florida , United-states , Miller-school , Gil-yosipovitch , Brian-kim , Santosh-mishra , Mark-hoon , Leigha-nattkemper , Icahn-school-of-medicine-at-mount-sinai , National-institutes-of-health , Miami-itch-center

Why It Can Feel Impossible to Stop Scratching an Itch

There’s a reason it feels so maddeningly good.

Miami , Florida , United-states , China , Shenzhen , Guangdong , Berkeley , California , Gil-yosipovitch , Zhou-feng-chen , Diana-bautista , Brians-kim

Why can't you stop scratching an itch?

There’s a reason it feels so maddeningly good.

California , United-states , Berkeley , Shenzhen , Guangdong , China , Miami , Florida , Diana-bautista , Brians-kim , Gil-yosipovitch , Zhou-feng-chen

Adults, children with chronic spontaneous urticaria differ in clinical features, response

Pediatric and adult chronic spontaneous urticaria exhibit distinct features, with adolescent presentations resembling those of adults more than those of younger children, according to a study published in Pediatric Allergy and Immunology. Younger children with chronic spontaneous urticaria (CSU) also have better responses to antihistamines than adolescents and adults, suggesting more severe and

Miami , Florida , United-states , American , Sanofi-regeneron , Arcutis-biotherapeutics , Gil-yosipovitch , American-academy-of-dermatology-annual-meeting , University-of-miami-miller-school-medicine , Pfizer , Novartis , Phillip-frost-department-of-dermatology

Pierre Fabre Compiles 3.3 Million Skin-related Data Points in One Source

Pierre Fabre Compiles 3.3 Million Skin-related Data Points in One Source
cosmeticsandtoiletries.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cosmeticsandtoiletries.com Daily Mail and Mail on Sunday newspapers.

Singapore , Florida , United-states , Miller-school , Miami , Perez-cullel , Pierre-fabre , Phillip-frost , Gil-yosipovitch , Miami-itch-center-dr , Miller-school-of-medicine , World-congress

Positive results for Sanofi/Regeneron's Dupixent published in Nature Medicine

Positive results for Sanofi/Regeneron's Dupixent published in Nature Medicine
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Miller-school , Florida , United-states , Miami , University-of-miami , Regeneron-dupixent , Gil-yosipovitch , Miller-school-of-medicine , Miami-itch-center , Nature-medicine ,

Difelikefalin improves itch in patients with chronic kidney disease

Itch intensity was reduced in patients with chronic kidney disease and moderate to severe pruritus who were treated with oral difelikefalin, according to a study.“Pruritus is a common, distressing condition that has been well characterized in patients receiving hemodialysis (HD),” Gil Yosipovitch, MD, of the department of dermatology and cutaneous surgery at the Miami Itch Center,

Miami , Florida , United-states , Gil-yosipovitch , University-of-miami-miller-school-medicine , Miami-itch-center , Miami-miller-school ,

Positive phase 3 data for Sanofi's Dupixent

Research showed significant improvements in signs and symptoms of prurigo nodularis - News - PharmaTimes

Miami , Florida , United-states , Gil-yosipovitch , European-academy-of-dermatology , Miami-itch-center , European-academy , Phase-3- , Upixent- , Anofi ,

Sanofi announces positive phase 3 data for Dupixent

Sanofi announces positive phase 3 data for Dupixent
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Miami , Florida , United-states , Gil-yosipovitch , European-academy-of-dermatology , Miami-itch-center , European-academy ,

Dupilumab Offers 'Clinically Meaningful' Improvements in PN

The monoclonal antibody dupilumab markedly reduces itch and the number of skin lesions in previously treated patients with severe prurigo nodularis, suggest results from a phase 2 trial.

Miami , Florida , United-states , Italy , Milan , Lombardia , University-of-miami , Gil-yosipovitch , European-academy-of-dermatology , Miami-itch-center , European-medicines-agency , Drug-administration